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CLINICAL INVESTIGATION OF BENTONITE-PETROLATUM
OINTMENTS AND OINTMENT BASES*
LESTER HOLLANDER, M.D., AND W. S. McCLENAHAN, PH.D.
Since September, 1943 we have conducted extensive clinical investigations at
the Pittsburgh Skin and Cancer Foundation with pastes and ointment bases
containing petrolatum and bentonite developed by the multiple fellowship on
petrolatum at Mellon Institute.
These pastes and ointment bases have all been of the washable, oil-in-water
emulsion type, and of considerable hydrophilic capability, owing to their benton-
ite content. Because of the presence of this colloid, the bases are physically
stable, even if subjected to high temperatures or freezing conditions. Thus they
may be sterilized by autoclaving, if the need exists for it, without causing them
to melt or break down in any way. The experience gained with these pastes and
ointment bases and a summary of the clinical findings are reported in this paper.
NOTES ON THE PHARMACOLOGY OF BENTONITE
The properties and uses of bentonite have been reviewed by Davis et al. (1)
and by Lesser (2). They have described it as a claylike substance derived from
volcanic ash, characterized by unique gelation and swelling properties attributable
to its strong affinity for water.
Although bentonite has been employed in medicine both internally and
externally, it is chiefly recommended as an ingredient of preparations for der-
matologic use. Its colloidal nature confers detergent properties and the ability
to absorb moisture and obnoxious debris from the surfaces of the body. Bento-
nite possesses salt-forming properties. In common with other hydrous aluminum
silicates it forms stable salts with organic bases, including alkaloids and proteins.
In an acid environment it removes proteins from water solution or suspension,
as insoluble salts. This property undoubtedly extends to the fixation of proteins
in serous exudates.
The inherent beneficial action of this colloidal substance may be enhanced
by the addition of therapeutically active substances to well-composed bentonite-
based preparations, for they possess excellent suspending and dispersing proper-
ties and present few problems related to pharmaceutical incompatibilities. If
they are properly formulated and compounded, preparations made with benton-
ite are suitably protective and tenaciously adherent; and because of their
strongly hydrophilic nature, they can be washed readily from the skin without
going through the messy procedure of cleansing with oil, so frequently necessary
with ointments and pastes of the non-hydrophilic variety. Thus these prepara-
tions should be more acceptable to the dermatologist and the patient alike than
are greasy ointments and pastes.
The official use of bentonite in the U.S.P. XIII is in Bentonite Magma, which
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contains 5 per cent of the material dispersed in water. This magma is employed
as a suspending medium in Chalk Mixture (used internally) and in Calamine
Lotion; it is also employed in the Neocalamine Lotion of N.F. VIII.
Brown (3) described the use of bentonite as a vehicle for medicinal and
cosmetic pastes. Kellogg (4) has advocated its use as a hand-protecting cream
against oils and greases in the following formula: bentonite 17, soap 4.5, water
78.5. Haraldson (5) has employed bentonite as a base to carry formalin as a
fungicidal agent. Griffon (6) used it in the preparation of an ointment base.
Jung (7) described its properties and the manner of its application as a thera-
peutic agent.
Tainter et al. (8) described bentonite under the name of Elkonite as a colloidal
clay composed chiefly of aluminum magnesium silicate, which is hydrophilic
and which swells in water to form a gel in 15 per cent concentration. They
stated that the addition of acid or alkali to fluid suspensions increases the
hydrophilic property as demonstrated by increases in viscosity. They alsa
spoke highly of the absorptive quality of this colloid. Further, they mentioned
that the most promising use for clinical purposes appeared to be as an ointment
base consisting of a 15 per cent gel.
Our experience, however, indicates that where an unmodified bentonite gel is
used as ointment base, it is likely to be unsatisfactory. If a layer of bentonite
gel is applied to the skin and allowed to dry, it forms a hard crust which contracts
and cracks as drying proceeds. The shrinkage produces an uncomfortable
pulling sensation, and the dry, cracked crust brings about mechanical irritation
which causes a friction-dermatitis. Therefore, we do not advise the use of a
bentonite gel alone as an ointment base under circumstances where complete
drying of the ointment can occur. This objection has also been raised in a recent
publication by Hopkins (9), who recommended the use of a number of additives
to overcome the difficulty. He used these bases in over 500 cases without finding
evidence of irritation or sensitization. He stated that the gels are suitable
carriers for sodium penicillin or any water soluble drug and also for sulfonamides,,
fatty acids, salicylic acid and other treatment agents which may be dissolved in
propylene glycol, alcohol or other suitable solvent before being added to the
prepared base. Sulfur, ammoniated mercury, zinc oxide and other insoluble
powders were said to be readily incorporated in these bases.
Hopkins pointed out that bentonite gels should not be used in wounds because
of the insoluble material so introduced. He also found them to be unsatisfactory
in intertrigo of the toes or elsewhere, because if applied thickly, they sometimes
form hard sharp granules as they dry out. However, the particular bentonite
formulations which we have investigated have been used successfully in this
manner in a number of individuals. In one chronic case of a dermatophytosis
involving the toes, these preparations combined with various fungistatic agents
have been used almost daily for the past four years, first for treatment and then
as a preventive measure, with no evidence of irritation appearing at any time.
Kulchar (10) advocated the use of 15 per cent suspensions of bentonite for
eruptions and also for essential pruritus of the anogenital region. Soldi and.
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Cuccia (11) described a paste made of bentonite, water and glycerin; they used
it as a substitute for fat or petrolatum as a base for ointments. Cox and Goedrich
(12) furnished a formula for a "Soluble Ointment Base"; this consisted of
glyceryl monostearate, glycerin, bentonite, and water. Maney and Jones (13)
stated that bentonite acts as a binder and can be used to prevent separation of
the ingredients of compound ointments; two per cent of the clay was added to
the mixture. Knowles et al. (14) credit Osborne with calling attention to the
value of bentonite in 3 per cent and 6 per cent aqueous suspension as a derma-
tologic topical liniment. Goodman (15) has described the use of bentonite
as a major ingredient in a number of formulas intended for application to the
skin or scalp. We have found, however, that the directions accompanying
many of these formulas are not adequate for the preparation of products of
pharmaceutical elegance and suitable for topical medication.
DESCRIPTION OF THE IIYDROPHILIC OINTMENT BASES USED IN THIS STUDY
The ointment bases embraced in this study consist essentially of emulsified
petroleum jelly, the emulsifier being hydrated bentonite. The physical proper-
ties of the emulsion are modified by the addition of small amounts of other
well-known emollients. The use of preservatives is essential, and several official
products are satisfactory. The oil phase content of the formulations has
ranged from 10 to 32 per cent, and satisfactory emulsions have been obtained
with bentonite concentrations of 13 to 17 per cent. A typical formula employed
is as follows:
Pet rolatum 32.0%
Bentonite 13.0
Methylparaben 0.1
Sodium Lauryl Sulfate 0.5
Water 54.4
100.0
Preparations containing low levels of petrolatum are satisfactory as the rub-in
type of ointment base which can be thoroughly dispersed on the skin like a
vanishing cream, but a considerably higher oil phase content was found to be
necessary whenever ointments were to be applied in thick layers. By thus
increasing the emollient qualities of the bases, drying effects and the possibility
of producing mechanical irritation of the skin were eliminated without impairing
the water-removability and other desirable properties of the ointments. These
high oil-content formulations are compatible with a wide variety of drugs, and
they have been employed successfully in the present study as the bases for several
ointments, as outlined in succeeding sections. Extensive clinical use has also
shown that they possess definite therapeutic properties without the addition of
any "active" medicament.
SKIN SENSITIVITY TEST
The initial question was whether emulsion bases of this type would cause any
skin irritation because of their inherent chemical properties or because of any
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latent allergenic qualities. Two hundred individuals, most of whom had some
form of dermatitis, were patch-tested with one of these ointment bases. These
patch tests were permitted to remain in position for a period of one week. At
the end of this time, the patches were removed and any reactions due to a primary
irritant effect of the ointment were noted and the sites of the patch tests were
then marked with indelible ink. The subjects were asked to return one week
later, when a second patch test was applied directly to the previously marked
area and again these patches were permitted to remain in place for one week.
At the end of this time the patches were removed and any reactions attributable
to sensitization by the first tests were noted. The results of this patch-testing
established the fact that this preparation was relatively safe for use. Only one
subject in the group of 200 was found to have a small area of irritation or dermati-
tis at the end of the first patch-testing period, which established the fact that,
in the group of individuals who were tested, this preparation was essentially
not a primary irritant. A dermatitis designated as + + was noted on the
same subject at the end of the second patch-testing period. This was interpreted
as a reaction of sensitization. This preparation therefore acted as a sensitizing
agent in only 1/2 of 1 per cent of the 200 individuals tested. In view of our
previous experience with ointments of all types, we consider this amount of
irritation to be unusually low.
OINTMENT BASE CONTAINING BORIC ACID
We added 5 per cent of boric acid to a petrolatum-bentonite gel emulsion base
containing 32 per cent of oil phase and applied it in the treatment of numerous
skin diseases. (While this experimental and clinical work was in progress we
became increasingly aware of some of the unsatisfactory effects attributable to
boric acid. Therefore, after the preliminary therapeutic testing reported in this
chapter had been completed, we investigated the same ointment base without
the addition of boric acid and found that the results in almost every instance
were equally, if not more, satisfactory.) Although the ointment base with
boric acid was used in the treatment of a great number of individuals, a complete
record of observations was made for only the first 157 patients. In some
instances the preparation was of primary therapeutic importance, while in others
it was used as an auxiliary treatment.
The ointment base containing boric acid was applied in 34 cases of eczema of
the leg. Good results were obtained in 30; no improvement occurred in 4
instances—an unusually high proportion of good results. The non-irritating
character and high absorptive ability of this preparation proved to be of great
therapeutic value. Ordinarily the ointment was applied in a thick layer, which
was covered with gauze, fixed with a loose circular bandage and kept in place
for a period of one week. Comparative tests were made using the ordinary
Lassar's paste (Zinc Oxide Paste, N .F.). In most instances the special ointment
base with boric acid was found to be superior. At the time for redressing we
found that the hydro.philic type ointment was more easily removed, that the
skin was softer and more pliable and that the inflamed area was made ready for
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reapplication with less effort and less discomfort than when the Lassar's paste
was used.
Twenty-three patients having dermatitis of the hands caused by soap and
water were treated. These included vesiculo-erythematous, dorsal nummular,
deeply fissured thick palinar, and the fine blistery interdigital varieties. Dress-
ings were fixed in place with bandage twice a week. The use of soap and water
was stopped, and 38 r of superficial X-ray was given once a week. Good results
were obtained in 16 patients; in 7 patients the results were indifferent or bad.
Fro. 1. SnowiNG AN INDOLENT Lao ULCER AND VESICUL0 DERMATITIS
SURROUNDING IT
In 22 patients suffering from leg ulcers of varied etiology this ointment was
used in an auxiliary capacity in the following manner: the skin surrounding the
leg ulcer was covered with a thick layer of the ointment, while the bed of the
ulcer was coated with sterile sulfanilamide crystals. The object of this pro-
cedure was (a) to protect the skin from the irritating discharges of the ulcer;
(b) to protect it also from the likelihood of becoming sensitized to the sulfanil-
amide. In 19 patients the results were satisfactory; in 3, the treatment had to
be discontinued, because of adverse effects.
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Sixteen patients were treated with the ointment during the final stages of
infectious eczematoid dermatitis, that is after vesiculation and pustule formation
had been effectively controlled, and where the therapeutic need consisted of
softening the dried and fissured skin; the treatment was satisfactory in 11 and
unsatisfactory in 5 patients. It must he noted especially however, that some
of the most satisfactory results from the use of this preparation occurred in this
group of individuals who are so notoriously ointment- and drug-sensitive.
Fro. 2. APPEARANCE OF LEG 4 WEEKs LATER
Of 9 patients presenting neurodermatitis, the ointment was satisfactory in 7,
unsatisfactory in 2.
Of 8 patients presenting pyoderma, it was satisfactory in 5, unsatisfactory in 3.
In 6 patients suffering from extensive psoriasis of the legs this ointment was
used in combination with autohemotherapy and liver injection. It worked
well in 5 instances.
In 7 patients presenting fixed dermatitis medicamentosa caused by one of the
sulfonamides, satisfactory results were obtained in 6 instances.
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Of 6 patients with atopic dermatitis, in 2 the results were as satisfactory as
with any other ointment used, while in 4 the applications had to be discontinued.
Of 4 patients presenting dermatitis of the fingertips, good results were obtained
in 3. The dermatitis of the fourth patient was found to be caused by the
application of Tincture Merthiolate; when this was stopped, the dermatitis
disappeared.
Six patients presenting dry, scaly, circinate dermatophytids responded well
to the ointment, which, of course, was supplementary to the treatment of the
primary dermatophytosis.
In 3 instances of acrodermatitis chronica atrophicans the results were good.
TABLE I
Summary of clinical findings with ointment containing 5 per cent boric acid in. petrolatum-
bentonite emulsion base
GOOD ISDIFFERXNT VNAC TOTAL
Leg eczema
Soap and water dermatitis of hands..
Leg ulcers
Infectious eczematoid dermatitis
30
16
19
11
4
4 3
3
5
34
23
22
16
Neurodermatitis 7 2 9
Pyoderma
Psoriasis of legs
Dermatitis medicamentosa (suif on-
5
5
3
1
8
6
amides)
Atopic dermatitis
Dermatitis of fingertips
Dermatophytids
Acrodermatitis chronica atrophicans.
Miscellaneous
6
2
3
6
3
10
1
3
1
4
7
6
4
6
3
13
Total 123 18 16 157
* The term "unsatisfactory" signifies that a dermatitis occurred, but in no case was it
more severe than that produced in the same patient by other topical medication.
In 13 patients presenting dermatitis of variable cause, including cosmetic
dermatitis, good results were obtained in 10, and no improvement occurred in 3.
Thus in a total of 157 patients treated with the ointment base containing
boric acid, good results were obtained in 123 (78.3 per cent), while 18 patients
(11.5 per cent) were not benefited and 16 (10.2 per cent) were adversely affected
(Table I).
MEEBROMIN N.F. AND SALICYLIC ACID OINTMENT
For the treatment of atopic dermatitis with secondary infection, an ointment
was prepared containing 1.5 per cent salicylic acid, 2.0 per cent merbromin,
and 96.5 per cent bentonite-petrolatum ointment base with high oil content.
In 8 patients with atopic dermatitis affecting the ears, neck, nape of neck, face,
scalp, and popliteal areas, this preparation was found to be of value in 3 patients
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and of no value in 4 individuals. One patient was irritated by the preparation
after keeping it on for 24 hours. The method of application of this preparation
was to spread it lightly over the affected areas, cover it with a piece of gauze and
keep it in place by a light bandage. The paste was permitted to stay in place
for 24 hours and was then removed. Any accumulation of this preparation was
easily washed off with tepid water.
OINTMENT OF COMPOUND TINCTURE OF BENZOIN
For dermatitis which occurred in senile atrophic skins, an ointment was
prepared containing 1 per cent of Compound Tincture of Benzoin in this emulsion
type base. This preparation was used on patients who presented a fine ery-
thematous squamous acrodermatitis and it was found to be quite satisfactory.
UNMEDICATED OINTMENT BASE
The satisfactory results obtained in the 123 of the first group of 157 patients
treated with the bentonite-petrolatum emulsion containing boric acid prompted
us to use this preparation in a routine fashion for over two years. During this
period we learned that when the ointment was stored for several months, various
sized crystals of boric acid would develop throughout its mass, thus handicapping
its usefulness. We also became aware of the reported toxic effects of boric acid
when it happens to become absorbed. These circumstances induced us to try
the bentonite-petrolatum emulsion base without the addition of boric Reid.
Our results were so satisfactory that since then we have continued to use the
unmedicated ointment base in all types of cases except those classified as dermati-
tis caused by soap and water, where we found that the boric acid ointment gave
superior results. Since the pH of the base itself is about 7.5 and that of the base
containing the boric acid is 5.5 it occurred to us that the slight acidity of the
latter was responsible for its greater value. We have investigated this possi-
bility, using an unmedicated ointment base adjusted to a pH of about 6.0 with a
citrate-phosphate buffer system. Observations in more than 100 patients bear
out the above belief since the latter base acts as efficiently as the ointment base
containing boric acid in the treatment of the dermatitis caused or aggravated
by soap and water.
We have also found that the petrolatum content of the base can be reduced to
25 per cent without impairing its emollient properties, a quality most desirable.
This latter preparation has advantages from a pharmaceutical standpoint, since
it is easier to compound, and also it makes a better stock base for the preparation
of ointments.'
SUMMARY AND CONCLUSIONS
A 4-year study has been made of a type of hydrophilic ointment base which
consists essentially of petrolatum emulsified in a bentonite gel. There are the
'We wish to thank Baybank Pharmaceuticals, Inc., Division of Chesebrough Manufac-
turing Company, Cons'd., New York, for their liberal contribution of "Terakon" Ointment
Base, which is essentially of this composition.
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following advantages to be gained by adding a preparation of this kind to the
list of dermatologic topical applications:
1. A new absorbing paste or ointment base is made available.
2. The preparation exhibits valuable therapeutic properties.
3. It is compatible, both pharmaceutically and therapeutically, with a wide
variety of useful drugs.
4. The oirtment base is composed of relatively non-irritating substances,
and allergic skin reactions to it are rare. (When patch tests were performed on
200 patients, only 1 individual, who was suffering from an atopic dermatitis,
showed a slight skin sensitivity to it.)
5. We, as others, have observed that the ue of topical applications for treating
chronic dermatoses over an extended period may result in a decrease or complete
loss of their therapeutic efficacy. In such cases it is advantageous to resort to
an entirely different type of preparation, and the bentonite-petrolatum ointment
base is suggested.
6. It is an alternative preparation for use instead of Lassar's type of paste.
7. By far the largest group of patients treated with this preparation during the
4-year study had skin diseases of the lower extremities. These disturbances
included hemostatic dermatitis, varicose dermatitis, dermatitis medicamentosa,
dermatitis which was the result of atrophy, and the dermatitis which came from
bath itch, dermatophytids and infectious eczernatoid dermatitis. Except in
certain instances noted in this report, the bentonite-petrolatum ointment base
was not only well tolerated, it was highly beneficial.
8. The ointment base is of value as a protective cup in treating leg ulcers,
as is also described.
9. In the vast majority of instances of soap and water dermatitis, which is
one of the more recalcitrant types of dermatoses, the effect of a bentonite-
petrolatum ointment base containing boric acid is excellent, and it rapidly
ameliorates the subjective symptoms of burning and itching. Equally satis-
factory results are obtained without the use of boric acid if the ointment base is
adjusted to a pH of about 6 with a citrate-phosphate buffer system.
10. The special colloidal properties of bentonite make the ointment base of
great value as a medium for absorbing moisture and obnoxious debris from the
surface of the skin.
11. The preparation can be removed from inflamed areas without the use of
liquid petrolatum or other oils, a procedure which is messy, lengthy and un-
pleasant; washing with a small quantity of water is ordinarily sufficient, and
except in the most unusual cases, this cleansing procedure does not increase the
irritation or inflammation of the skin.
The authors wish to take this opportunity to thank Dr. George D. Beal and
Dr. W. A. I{amor of Mellon Institute for their interest and advice in this study
and in the preparation of the manuscript. They also wish to express their
appreciation of the support of the Chesebrough Manufacturing Company,
Consolidated, donor of the multiple fellowship on petrolatum.
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